nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—Ezetimibe—atherosclerosis	0.439	1	CrCtD
Pimozide—HRH1—atherosclerosis	0.134	1	CbGaD
Pimozide—Fluspirilene—Ezetimibe—atherosclerosis	0.117	0.552	CrCrCtD
Pimozide—Flunarizine—Ezetimibe—atherosclerosis	0.0946	0.448	CrCrCtD
Pimozide—CYP3A7—Simvastatin—atherosclerosis	0.0102	0.0703	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0102	0.0703	CbGbCtD
Pimozide—CYP3A7—Lovastatin—atherosclerosis	0.00996	0.0687	CbGbCtD
Pimozide—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.00996	0.0687	CbGbCtD
Pimozide—CYP3A5—Rosuvastatin—atherosclerosis	0.00821	0.0567	CbGbCtD
Pimozide—CYP3A5—Simvastatin—atherosclerosis	0.00763	0.0527	CbGbCtD
Pimozide—CYP3A5—Pravastatin—atherosclerosis	0.00747	0.0516	CbGbCtD
Pimozide—CYP3A5—Lovastatin—atherosclerosis	0.00747	0.0516	CbGbCtD
Pimozide—CYP2C19—Rosuvastatin—atherosclerosis	0.00662	0.0457	CbGbCtD
Pimozide—CYP2C19—Simvastatin—atherosclerosis	0.00616	0.0425	CbGbCtD
Pimozide—CYP2C19—Lovastatin—atherosclerosis	0.00602	0.0416	CbGbCtD
Pimozide—CYP2D6—Niacin—atherosclerosis	0.00592	0.0409	CbGbCtD
Pimozide—ABCB1—Ezetimibe—atherosclerosis	0.00534	0.0369	CbGbCtD
Pimozide—ABCB1—Simvastatin—atherosclerosis	0.00497	0.0343	CbGbCtD
Pimozide—ABCB1—Pravastatin—atherosclerosis	0.00486	0.0336	CbGbCtD
Pimozide—ABCB1—Lovastatin—atherosclerosis	0.00486	0.0336	CbGbCtD
Pimozide—CYP2D6—Simvastatin—atherosclerosis	0.00468	0.0323	CbGbCtD
Pimozide—CYP2D6—Pravastatin—atherosclerosis	0.00458	0.0316	CbGbCtD
Pimozide—CYP2D6—Lovastatin—atherosclerosis	0.00458	0.0316	CbGbCtD
Pimozide—CYP3A4—Ezetimibe—atherosclerosis	0.0032	0.0221	CbGbCtD
Pimozide—CYP3A4—Rosuvastatin—atherosclerosis	0.0032	0.0221	CbGbCtD
Pimozide—CYP3A4—Simvastatin—atherosclerosis	0.00298	0.0205	CbGbCtD
Pimozide—CYP3A4—Pravastatin—atherosclerosis	0.00291	0.0201	CbGbCtD
Pimozide—CYP3A4—Lovastatin—atherosclerosis	0.00291	0.0201	CbGbCtD
Pimozide—Ezetimibe—ABCG8—atherosclerosis	0.000818	0.329	CrCbGaD
Pimozide—Loss of libido—Lovastatin—atherosclerosis	0.000767	0.0274	CcSEcCtD
Pimozide—HTR2A—arteriole—atherosclerosis	0.000761	0.119	CbGeAlD
Pimozide—Loss of libido—Simvastatin—atherosclerosis	0.000717	0.0257	CcSEcCtD
Pimozide—Loss of libido—Pravastatin—atherosclerosis	0.000649	0.0232	CcSEcCtD
Pimozide—Ezetimibe—SOAT1—atherosclerosis	0.00062	0.249	CrCbGaD
Pimozide—Faecal incontinence—Niacin—atherosclerosis	0.000603	0.0216	CcSEcCtD
Pimozide—Ezetimibe—ABCG5—atherosclerosis	0.000527	0.212	CrCbGaD
Pimozide—Blood disorder—Rosuvastatin—atherosclerosis	0.0005	0.0179	CcSEcCtD
Pimozide—HTR2A—vein—atherosclerosis	0.000454	0.0711	CbGeAlD
Pimozide—Endocrine disorder—Simvastatin—atherosclerosis	0.0004	0.0143	CcSEcCtD
Pimozide—Gynaecomastia—Rosuvastatin—atherosclerosis	0.000374	0.0134	CcSEcCtD
Pimozide—Cataract—Lovastatin—atherosclerosis	0.000372	0.0133	CcSEcCtD
Pimozide—Cataract—Simvastatin—atherosclerosis	0.000348	0.0124	CcSEcCtD
Pimozide—Nocturia—Pravastatin—atherosclerosis	0.000323	0.0115	CcSEcCtD
Pimozide—Gynaecomastia—Lovastatin—atherosclerosis	0.000317	0.0113	CcSEcCtD
Pimozide—Cataract—Pravastatin—atherosclerosis	0.000315	0.0113	CcSEcCtD
Pimozide—CALM2—artery—atherosclerosis	0.000305	0.0478	CbGeAlD
Pimozide—CALM1—artery—atherosclerosis	0.000304	0.0475	CbGeAlD
Pimozide—HTR2A—hindlimb—atherosclerosis	0.000302	0.0472	CbGeAlD
Pimozide—Eructation—Niacin—atherosclerosis	0.000299	0.0107	CcSEcCtD
Pimozide—Gynaecomastia—Simvastatin—atherosclerosis	0.000296	0.0106	CcSEcCtD
Pimozide—Haemolytic anaemia—Lovastatin—atherosclerosis	0.000285	0.0102	CcSEcCtD
Pimozide—Breast disorder—Rosuvastatin—atherosclerosis	0.000274	0.00981	CcSEcCtD
Pimozide—Gynaecomastia—Pravastatin—atherosclerosis	0.000268	0.00959	CcSEcCtD
Pimozide—Haemolytic anaemia—Simvastatin—atherosclerosis	0.000266	0.00953	CcSEcCtD
Pimozide—HTR2A—appendage—atherosclerosis	0.000259	0.0405	CbGeAlD
Pimozide—CALM2—endothelium—atherosclerosis	0.000258	0.0403	CbGeAlD
Pimozide—CALM1—endothelium—atherosclerosis	0.000256	0.0402	CbGeAlD
Pimozide—Haemolytic anaemia—Pravastatin—atherosclerosis	0.000241	0.00861	CcSEcCtD
Pimozide—CALM2—blood vessel—atherosclerosis	0.000238	0.0372	CbGeAlD
Pimozide—CALM1—blood vessel—atherosclerosis	0.000236	0.037	CbGeAlD
Pimozide—Depression—Rosuvastatin—atherosclerosis	0.000233	0.00834	CcSEcCtD
Pimozide—Cramp muscle—Lovastatin—atherosclerosis	0.000231	0.00828	CcSEcCtD
Pimozide—Breast disorder—Ezetimibe—atherosclerosis	0.000228	0.00815	CcSEcCtD
Pimozide—Cramp muscle—Ezetimibe—atherosclerosis	0.000227	0.00812	CcSEcCtD
Pimozide—Eosinophilia—Lovastatin—atherosclerosis	0.00022	0.00787	CcSEcCtD
Pimozide—Cramp muscle—Simvastatin—atherosclerosis	0.000217	0.00775	CcSEcCtD
Pimozide—Eosinophilia—Ezetimibe—atherosclerosis	0.000216	0.00772	CcSEcCtD
Pimozide—Abdominal discomfort—Lovastatin—atherosclerosis	0.000213	0.00762	CcSEcCtD
Pimozide—Urinary retention—Niacin—atherosclerosis	0.00021	0.00751	CcSEcCtD
Pimozide—Eosinophilia—Simvastatin—atherosclerosis	0.000206	0.00736	CcSEcCtD
Pimozide—Erectile dysfunction—Lovastatin—atherosclerosis	0.000205	0.00732	CcSEcCtD
Pimozide—Orthostatic hypotension—Niacin—atherosclerosis	0.000202	0.00721	CcSEcCtD
Pimozide—Erectile dysfunction—Ezetimibe—atherosclerosis	0.000201	0.00718	CcSEcCtD
Pimozide—Abdominal discomfort—Simvastatin—atherosclerosis	0.000199	0.00713	CcSEcCtD
Pimozide—Cramp muscle—Pravastatin—atherosclerosis	0.000196	0.007	CcSEcCtD
Pimozide—Erectile dysfunction—Simvastatin—atherosclerosis	0.000191	0.00685	CcSEcCtD
Pimozide—Dysphagia—Niacin—atherosclerosis	0.000191	0.00683	CcSEcCtD
Pimozide—Eosinophilia—Pravastatin—atherosclerosis	0.000186	0.00665	CcSEcCtD
Pimozide—HTR2A—artery—atherosclerosis	0.000185	0.029	CbGeAlD
Pimozide—Depression—Simvastatin—atherosclerosis	0.000185	0.00661	CcSEcCtD
Pimozide—Mental disorder—Rosuvastatin—atherosclerosis	0.000184	0.00658	CcSEcCtD
Pimozide—Erectile dysfunction—Niacin—atherosclerosis	0.000176	0.00629	CcSEcCtD
Pimozide—Erectile dysfunction—Pravastatin—atherosclerosis	0.000173	0.00619	CcSEcCtD
Pimozide—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000171	0.00613	CcSEcCtD
Pimozide—Weight increased—Pravastatin—atherosclerosis	0.000171	0.00612	CcSEcCtD
Pimozide—Weight decreased—Pravastatin—atherosclerosis	0.00017	0.00608	CcSEcCtD
Pimozide—Depression—Pravastatin—atherosclerosis	0.000167	0.00598	CcSEcCtD
Pimozide—Sweating—Niacin—atherosclerosis	0.000163	0.00584	CcSEcCtD
Pimozide—HTR2A—endothelium—atherosclerosis	0.000156	0.0245	CbGeAlD
Pimozide—Myalgia—Rosuvastatin—atherosclerosis	0.000156	0.00556	CcSEcCtD
Pimozide—Mental disorder—Ezetimibe—atherosclerosis	0.000153	0.00547	CcSEcCtD
Pimozide—Muscle spasms—Lovastatin—atherosclerosis	0.000149	0.00532	CcSEcCtD
Pimozide—Visual impairment—Niacin—atherosclerosis	0.000147	0.00527	CcSEcCtD
Pimozide—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000146	0.00523	CcSEcCtD
Pimozide—Muscle spasms—Ezetimibe—atherosclerosis	0.000146	0.00522	CcSEcCtD
Pimozide—Vision blurred—Lovastatin—atherosclerosis	0.000146	0.00522	CcSEcCtD
Pimozide—Mental disorder—Simvastatin—atherosclerosis	0.000146	0.00521	CcSEcCtD
Pimozide—Tremor—Lovastatin—atherosclerosis	0.000145	0.00519	CcSEcCtD
Pimozide—Visual impairment—Pravastatin—atherosclerosis	0.000145	0.00518	CcSEcCtD
Pimozide—HTR2A—blood vessel—atherosclerosis	0.000144	0.0226	CbGeAlD
Pimozide—Eye disorder—Niacin—atherosclerosis	0.000143	0.00511	CcSEcCtD
Pimozide—Anaemia—Ezetimibe—atherosclerosis	0.00014	0.00502	CcSEcCtD
Pimozide—Cardiac disorder—Pravastatin—atherosclerosis	0.00014	0.00499	CcSEcCtD
Pimozide—CYP3A7—liver—atherosclerosis	0.000139	0.0218	CbGeAlD
Pimozide—Muscle spasms—Simvastatin—atherosclerosis	0.000139	0.00498	CcSEcCtD
Pimozide—Leukopenia—Lovastatin—atherosclerosis	0.000139	0.00496	CcSEcCtD
Pimozide—Vision blurred—Simvastatin—atherosclerosis	0.000136	0.00488	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000136	0.00486	CcSEcCtD
Pimozide—Tremor—Simvastatin—atherosclerosis	0.000136	0.00485	CcSEcCtD
Pimozide—Insomnia—Rosuvastatin—atherosclerosis	0.000135	0.00482	CcSEcCtD
Pimozide—Palpitations—Ezetimibe—atherosclerosis	0.000134	0.0048	CcSEcCtD
Pimozide—Anaemia—Simvastatin—atherosclerosis	0.000134	0.00479	CcSEcCtD
Pimozide—Astemizole—HRH1—atherosclerosis	0.000133	0.0536	CrCbGaD
Pimozide—CHRM2—cardiovascular system—atherosclerosis	0.000133	0.0208	CbGeAlD
Pimozide—Myalgia—Lovastatin—atherosclerosis	0.000132	0.00471	CcSEcCtD
Pimozide—Chest pain—Lovastatin—atherosclerosis	0.000132	0.00471	CcSEcCtD
Pimozide—Hypertension—Ezetimibe—atherosclerosis	0.000131	0.00469	CcSEcCtD
Pimozide—Leukopenia—Simvastatin—atherosclerosis	0.00013	0.00464	CcSEcCtD
Pimozide—Myalgia—Ezetimibe—atherosclerosis	0.000129	0.00462	CcSEcCtD
Pimozide—Chest pain—Ezetimibe—atherosclerosis	0.000129	0.00462	CcSEcCtD
Pimozide—Dry mouth—Lovastatin—atherosclerosis	0.000129	0.00461	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000128	0.00459	CcSEcCtD
Pimozide—Muscle spasms—Niacin—atherosclerosis	0.000128	0.00457	CcSEcCtD
Pimozide—Constipation—Rosuvastatin—atherosclerosis	0.000127	0.00456	CcSEcCtD
Pimozide—Dry mouth—Ezetimibe—atherosclerosis	0.000126	0.00452	CcSEcCtD
Pimozide—Muscle spasms—Pravastatin—atherosclerosis	0.000126	0.0045	CcSEcCtD
Pimozide—Vision blurred—Niacin—atherosclerosis	0.000125	0.00448	CcSEcCtD
Pimozide—Vision blurred—Pravastatin—atherosclerosis	0.000123	0.00441	CcSEcCtD
Pimozide—Chest pain—Simvastatin—atherosclerosis	0.000123	0.00441	CcSEcCtD
Pimozide—Myalgia—Simvastatin—atherosclerosis	0.000123	0.00441	CcSEcCtD
Pimozide—Tremor—Pravastatin—atherosclerosis	0.000123	0.00439	CcSEcCtD
Pimozide—CALM2—connective tissue—atherosclerosis	0.000122	0.0191	CbGeAlD
Pimozide—Nervous system disorder—Ezetimibe—atherosclerosis	0.000122	0.00435	CcSEcCtD
Pimozide—CALM1—connective tissue—atherosclerosis	0.000121	0.019	CbGeAlD
Pimozide—Anaemia—Pravastatin—atherosclerosis	0.000121	0.00433	CcSEcCtD
Pimozide—Anorexia—Lovastatin—atherosclerosis	0.00012	0.00431	CcSEcCtD
Pimozide—Skin disorder—Ezetimibe—atherosclerosis	0.00012	0.00431	CcSEcCtD
Pimozide—Syncope—Niacin—atherosclerosis	0.000119	0.00427	CcSEcCtD
Pimozide—CALM3—adipose tissue—atherosclerosis	0.000119	0.0186	CbGeAlD
Pimozide—Leukopenia—Niacin—atherosclerosis	0.000119	0.00426	CcSEcCtD
Pimozide—Sertindole—HRH1—atherosclerosis	0.000119	0.0478	CrCbGaD
Pimozide—CYP3A7-CYP3A51P—liver—atherosclerosis	0.000118	0.0186	CbGeAlD
Pimozide—Urticaria—Rosuvastatin—atherosclerosis	0.000118	0.00424	CcSEcCtD
Pimozide—Palpitations—Niacin—atherosclerosis	0.000117	0.0042	CcSEcCtD
Pimozide—Leukopenia—Pravastatin—atherosclerosis	0.000117	0.00419	CcSEcCtD
Pimozide—Loss of consciousness—Niacin—atherosclerosis	0.000117	0.00418	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000115	0.00412	CcSEcCtD
Pimozide—Insomnia—Lovastatin—atherosclerosis	0.000114	0.00409	CcSEcCtD
Pimozide—Myalgia—Niacin—atherosclerosis	0.000113	0.00405	CcSEcCtD
Pimozide—Hypertension—Pravastatin—atherosclerosis	0.000113	0.00404	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000113	0.00404	CcSEcCtD
Pimozide—Anorexia—Simvastatin—atherosclerosis	0.000113	0.00403	CcSEcCtD
Pimozide—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000112	0.00402	CcSEcCtD
Pimozide—Insomnia—Ezetimibe—atherosclerosis	0.000112	0.00401	CcSEcCtD
Pimozide—Myalgia—Pravastatin—atherosclerosis	0.000111	0.00399	CcSEcCtD
Pimozide—Chest pain—Pravastatin—atherosclerosis	0.000111	0.00399	CcSEcCtD
Pimozide—Dry mouth—Niacin—atherosclerosis	0.000111	0.00396	CcSEcCtD
Pimozide—Decreased appetite—Lovastatin—atherosclerosis	0.00011	0.00393	CcSEcCtD
Pimozide—Constipation—Lovastatin—atherosclerosis	0.000108	0.00387	CcSEcCtD
Pimozide—HTR1A—cardiovascular system—atherosclerosis	0.000108	0.0169	CbGeAlD
Pimozide—Decreased appetite—Ezetimibe—atherosclerosis	0.000108	0.00385	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000108	0.00385	CcSEcCtD
Pimozide—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000107	0.00383	CcSEcCtD
Pimozide—Asthenia—Rosuvastatin—atherosclerosis	0.000107	0.00383	CcSEcCtD
Pimozide—Insomnia—Simvastatin—atherosclerosis	0.000107	0.00382	CcSEcCtD
Pimozide—Shock—Niacin—atherosclerosis	0.000107	0.00382	CcSEcCtD
Pimozide—CALM2—cardiovascular system—atherosclerosis	0.000106	0.0166	CbGeAlD
Pimozide—Constipation—Ezetimibe—atherosclerosis	0.000106	0.00379	CcSEcCtD
Pimozide—Tachycardia—Niacin—atherosclerosis	0.000106	0.00379	CcSEcCtD
Pimozide—CALM1—cardiovascular system—atherosclerosis	0.000105	0.0165	CbGeAlD
Pimozide—Pruritus—Rosuvastatin—atherosclerosis	0.000105	0.00377	CcSEcCtD
Pimozide—Skin disorder—Niacin—atherosclerosis	0.000105	0.00377	CcSEcCtD
Pimozide—Hyperhidrosis—Niacin—atherosclerosis	0.000105	0.00375	CcSEcCtD
Pimozide—Anorexia—Niacin—atherosclerosis	0.000103	0.0037	CcSEcCtD
Pimozide—Hyperhidrosis—Pravastatin—atherosclerosis	0.000103	0.00369	CcSEcCtD
Pimozide—Decreased appetite—Simvastatin—atherosclerosis	0.000103	0.00368	CcSEcCtD
Pimozide—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000102	0.00365	CcSEcCtD
Pimozide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000102	0.00365	CcSEcCtD
Pimozide—Anorexia—Pravastatin—atherosclerosis	0.000102	0.00364	CcSEcCtD
Pimozide—Hypotension—Niacin—atherosclerosis	0.000101	0.00363	CcSEcCtD
Pimozide—Constipation—Simvastatin—atherosclerosis	0.000101	0.00362	CcSEcCtD
Pimozide—Urticaria—Lovastatin—atherosclerosis	0.0001	0.00359	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Niacin—atherosclerosis	9.89e-05	0.00354	CcSEcCtD
Pimozide—Dizziness—Rosuvastatin—atherosclerosis	9.86e-05	0.00353	CcSEcCtD
Pimozide—Urticaria—Ezetimibe—atherosclerosis	9.84e-05	0.00352	CcSEcCtD
Pimozide—Insomnia—Niacin—atherosclerosis	9.81e-05	0.00351	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	9.73e-05	0.00348	CcSEcCtD
Pimozide—Fluspirilene—HRH1—atherosclerosis	9.69e-05	0.039	CrCbGaD
Pimozide—Insomnia—Pravastatin—atherosclerosis	9.66e-05	0.00346	CcSEcCtD
Pimozide—Somnolence—Niacin—atherosclerosis	9.65e-05	0.00345	CcSEcCtD
Pimozide—KCNH2—cardiovascular system—atherosclerosis	9.6e-05	0.015	CbGeAlD
Pimozide—Fexofenadine—HRH1—atherosclerosis	9.51e-05	0.0382	CrCbGaD
Pimozide—ABCB1—blood vessel—atherosclerosis	9.44e-05	0.0148	CbGeAlD
Pimozide—Decreased appetite—Niacin—atherosclerosis	9.43e-05	0.00337	CcSEcCtD
Pimozide—Rash—Rosuvastatin—atherosclerosis	9.4e-05	0.00336	CcSEcCtD
Pimozide—Dermatitis—Rosuvastatin—atherosclerosis	9.39e-05	0.00336	CcSEcCtD
Pimozide—Urticaria—Simvastatin—atherosclerosis	9.39e-05	0.00336	CcSEcCtD
Pimozide—Gastrointestinal disorder—Niacin—atherosclerosis	9.37e-05	0.00335	CcSEcCtD
Pimozide—CALM2—adipose tissue—atherosclerosis	9.35e-05	0.0146	CbGeAlD
Pimozide—Headache—Rosuvastatin—atherosclerosis	9.34e-05	0.00334	CcSEcCtD
Pimozide—CALM1—adipose tissue—atherosclerosis	9.3e-05	0.0146	CbGeAlD
Pimozide—Decreased appetite—Pravastatin—atherosclerosis	9.29e-05	0.00332	CcSEcCtD
Pimozide—Constipation—Pravastatin—atherosclerosis	9.14e-05	0.00327	CcSEcCtD
Pimozide—Asthenia—Lovastatin—atherosclerosis	9.06e-05	0.00324	CcSEcCtD
Pimozide—Pruritus—Lovastatin—atherosclerosis	8.94e-05	0.0032	CcSEcCtD
Pimozide—Asthenia—Ezetimibe—atherosclerosis	8.89e-05	0.00318	CcSEcCtD
Pimozide—Nausea—Rosuvastatin—atherosclerosis	8.85e-05	0.00317	CcSEcCtD
Pimozide—HRH1—connective tissue—atherosclerosis	8.84e-05	0.0139	CbGeAlD
Pimozide—Pruritus—Ezetimibe—atherosclerosis	8.77e-05	0.00314	CcSEcCtD
Pimozide—Diarrhoea—Lovastatin—atherosclerosis	8.64e-05	0.00309	CcSEcCtD
Pimozide—Urticaria—Niacin—atherosclerosis	8.62e-05	0.00308	CcSEcCtD
Pimozide—Urticaria—Pravastatin—atherosclerosis	8.49e-05	0.00304	CcSEcCtD
Pimozide—Asthenia—Simvastatin—atherosclerosis	8.48e-05	0.00303	CcSEcCtD
Pimozide—Diarrhoea—Ezetimibe—atherosclerosis	8.48e-05	0.00303	CcSEcCtD
Pimozide—Pruritus—Simvastatin—atherosclerosis	8.36e-05	0.00299	CcSEcCtD
Pimozide—Dizziness—Lovastatin—atherosclerosis	8.35e-05	0.00299	CcSEcCtD
Pimozide—CALM3—liver—atherosclerosis	8.35e-05	0.0131	CbGeAlD
Pimozide—Dizziness—Ezetimibe—atherosclerosis	8.19e-05	0.00293	CcSEcCtD
Pimozide—Diarrhoea—Simvastatin—atherosclerosis	8.09e-05	0.00289	CcSEcCtD
Pimozide—Vomiting—Lovastatin—atherosclerosis	8.03e-05	0.00287	CcSEcCtD
Pimozide—Rash—Lovastatin—atherosclerosis	7.97e-05	0.00285	CcSEcCtD
Pimozide—Dermatitis—Lovastatin—atherosclerosis	7.96e-05	0.00285	CcSEcCtD
Pimozide—Headache—Lovastatin—atherosclerosis	7.91e-05	0.00283	CcSEcCtD
Pimozide—Vomiting—Ezetimibe—atherosclerosis	7.88e-05	0.00282	CcSEcCtD
Pimozide—Flunarizine—HRH1—atherosclerosis	7.86e-05	0.0316	CrCbGaD
Pimozide—Dizziness—Simvastatin—atherosclerosis	7.81e-05	0.0028	CcSEcCtD
Pimozide—Rash—Ezetimibe—atherosclerosis	7.81e-05	0.0028	CcSEcCtD
Pimozide—Dermatitis—Ezetimibe—atherosclerosis	7.81e-05	0.00279	CcSEcCtD
Pimozide—Asthenia—Niacin—atherosclerosis	7.78e-05	0.00279	CcSEcCtD
Pimozide—Headache—Ezetimibe—atherosclerosis	7.76e-05	0.00278	CcSEcCtD
Pimozide—Pruritus—Niacin—atherosclerosis	7.68e-05	0.00275	CcSEcCtD
Pimozide—Asthenia—Pravastatin—atherosclerosis	7.67e-05	0.00274	CcSEcCtD
Pimozide—Pruritus—Pravastatin—atherosclerosis	7.56e-05	0.0027	CcSEcCtD
Pimozide—Vomiting—Simvastatin—atherosclerosis	7.51e-05	0.00269	CcSEcCtD
Pimozide—Nausea—Lovastatin—atherosclerosis	7.5e-05	0.00268	CcSEcCtD
Pimozide—Rash—Simvastatin—atherosclerosis	7.45e-05	0.00267	CcSEcCtD
Pimozide—Dermatitis—Simvastatin—atherosclerosis	7.44e-05	0.00266	CcSEcCtD
Pimozide—Diarrhoea—Niacin—atherosclerosis	7.42e-05	0.00266	CcSEcCtD
Pimozide—Headache—Simvastatin—atherosclerosis	7.4e-05	0.00265	CcSEcCtD
Pimozide—CYP2E1—cardiovascular system—atherosclerosis	7.39e-05	0.0116	CbGeAlD
Pimozide—HTR2A—connective tissue—atherosclerosis	7.39e-05	0.0116	CbGeAlD
Pimozide—Nausea—Ezetimibe—atherosclerosis	7.36e-05	0.00263	CcSEcCtD
Pimozide—Diarrhoea—Pravastatin—atherosclerosis	7.31e-05	0.00262	CcSEcCtD
Pimozide—Dizziness—Niacin—atherosclerosis	7.18e-05	0.00257	CcSEcCtD
Pimozide—Dizziness—Pravastatin—atherosclerosis	7.06e-05	0.00253	CcSEcCtD
Pimozide—Nausea—Simvastatin—atherosclerosis	7.02e-05	0.00251	CcSEcCtD
Pimozide—CYP3A5—adipose tissue—atherosclerosis	6.99e-05	0.0109	CbGeAlD
Pimozide—Vomiting—Niacin—atherosclerosis	6.9e-05	0.00247	CcSEcCtD
Pimozide—Rash—Niacin—atherosclerosis	6.84e-05	0.00245	CcSEcCtD
Pimozide—Dermatitis—Niacin—atherosclerosis	6.84e-05	0.00245	CcSEcCtD
Pimozide—Headache—Niacin—atherosclerosis	6.8e-05	0.00243	CcSEcCtD
Pimozide—Vomiting—Pravastatin—atherosclerosis	6.79e-05	0.00243	CcSEcCtD
Pimozide—HRH1—adipose tissue—atherosclerosis	6.79e-05	0.0106	CbGeAlD
Pimozide—Rash—Pravastatin—atherosclerosis	6.74e-05	0.00241	CcSEcCtD
Pimozide—Dermatitis—Pravastatin—atherosclerosis	6.73e-05	0.00241	CcSEcCtD
Pimozide—Headache—Pravastatin—atherosclerosis	6.69e-05	0.00239	CcSEcCtD
Pimozide—CALM2—liver—atherosclerosis	6.55e-05	0.0103	CbGeAlD
Pimozide—CALM1—liver—atherosclerosis	6.52e-05	0.0102	CbGeAlD
Pimozide—Nausea—Niacin—atherosclerosis	6.45e-05	0.00231	CcSEcCtD
Pimozide—HTR2A—cardiovascular system—atherosclerosis	6.43e-05	0.0101	CbGeAlD
Pimozide—Nausea—Pravastatin—atherosclerosis	6.35e-05	0.00227	CcSEcCtD
Pimozide—CYP2C19—liver—atherosclerosis	6.22e-05	0.00975	CbGeAlD
Pimozide—CYP1A2—liver—atherosclerosis	5.08e-05	0.00796	CbGeAlD
Pimozide—CYP3A5—liver—atherosclerosis	4.9e-05	0.00768	CbGeAlD
Pimozide—CYP2E1—liver—atherosclerosis	4.57e-05	0.00716	CbGeAlD
Pimozide—ABCB1—cardiovascular system—atherosclerosis	4.21e-05	0.0066	CbGeAlD
Pimozide—HTR2A—liver—atherosclerosis	3.97e-05	0.00622	CbGeAlD
Pimozide—ABCB1—adipose tissue—atherosclerosis	3.71e-05	0.00582	CbGeAlD
Pimozide—CYP3A4—liver—atherosclerosis	3.68e-05	0.00576	CbGeAlD
Pimozide—CYP2D6—liver—atherosclerosis	3.62e-05	0.00567	CbGeAlD
Pimozide—ABCB1—liver—atherosclerosis	2.6e-05	0.00408	CbGeAlD
Pimozide—ABCB1—Metabolism—APOA1—atherosclerosis	9.62e-07	2.81e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—NOS3—atherosclerosis	9.62e-07	2.81e-05	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—AKT1—atherosclerosis	9.61e-07	2.8e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—NFKB1—atherosclerosis	9.55e-07	2.79e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—NFKB1—atherosclerosis	9.55e-07	2.79e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—NOS3—atherosclerosis	9.51e-07	2.78e-05	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—AKT1—atherosclerosis	9.5e-07	2.77e-05	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—AKT1—atherosclerosis	9.5e-07	2.77e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—IL6—atherosclerosis	9.46e-07	2.76e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—GSTM1—atherosclerosis	9.44e-07	2.75e-05	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—AKT1—atherosclerosis	9.43e-07	2.75e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—MAPK8—atherosclerosis	9.39e-07	2.74e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—MAPK8—atherosclerosis	9.39e-07	2.74e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—PIK3CG—atherosclerosis	9.37e-07	2.73e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—PIK3CG—atherosclerosis	9.37e-07	2.73e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—VEGFA—atherosclerosis	9.36e-07	2.73e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—AGT—atherosclerosis	9.36e-07	2.73e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—NOS3—atherosclerosis	9.3e-07	2.71e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—NOS3—atherosclerosis	9.3e-07	2.71e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—MAPK3—atherosclerosis	9.28e-07	2.71e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—VEGFA—atherosclerosis	9.27e-07	2.7e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—STAT3—atherosclerosis	9.27e-07	2.7e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—LPL—atherosclerosis	9.26e-07	2.7e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—STAT3—atherosclerosis	9.18e-07	2.68e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—INS—atherosclerosis	9.17e-07	2.68e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—APOE—atherosclerosis	9.17e-07	2.68e-05	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—AKT1—atherosclerosis	9.12e-07	2.66e-05	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—AKT1—atherosclerosis	9.12e-07	2.66e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ABCA1—atherosclerosis	9.11e-07	2.66e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—CAV1—atherosclerosis	9.08e-07	2.65e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—APOA1—atherosclerosis	9.06e-07	2.64e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—GPX1—atherosclerosis	9.04e-07	2.64e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CCL2—atherosclerosis	9.02e-07	2.63e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MMP9—atherosclerosis	9e-07	2.63e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PIK3CG—atherosclerosis	8.99e-07	2.62e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—MAPK3—atherosclerosis	8.97e-07	2.62e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—MAPK3—atherosclerosis	8.97e-07	2.62e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—NFKB1—atherosclerosis	8.9e-07	2.6e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—STAT3—atherosclerosis	8.87e-07	2.59e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—INS—atherosclerosis	8.87e-07	2.59e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—INS—atherosclerosis	8.87e-07	2.59e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IGF1—atherosclerosis	8.87e-07	2.59e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—MAPK3—atherosclerosis	8.85e-07	2.58e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—PTGS2—atherosclerosis	8.85e-07	2.58e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—PTGS2—atherosclerosis	8.83e-07	2.58e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CD36—atherosclerosis	8.8e-07	2.57e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—PTGS2—atherosclerosis	8.8e-07	2.57e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PIK3CG—atherosclerosis	8.78e-07	2.56e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—MAPK3—atherosclerosis	8.77e-07	2.56e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MAPK8—atherosclerosis	8.75e-07	2.55e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CXCL8—atherosclerosis	8.73e-07	2.55e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CCL2—atherosclerosis	8.73e-07	2.55e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CCL2—atherosclerosis	8.73e-07	2.55e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—AKT1—atherosclerosis	8.72e-07	2.55e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PPARG—atherosclerosis	8.68e-07	2.53e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CXCL8—atherosclerosis	8.59e-07	2.51e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TGFB1—atherosclerosis	8.59e-07	2.51e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—STAT3—atherosclerosis	8.58e-07	2.5e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—STAT3—atherosclerosis	8.58e-07	2.5e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IGF1—atherosclerosis	8.58e-07	2.5e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IGF1—atherosclerosis	8.58e-07	2.5e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CXCL8—atherosclerosis	8.57e-07	2.5e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—INS—atherosclerosis	8.51e-07	2.48e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—PTGS2—atherosclerosis	8.51e-07	2.48e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—PTGS2—atherosclerosis	8.51e-07	2.48e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TGFB1—atherosclerosis	8.51e-07	2.48e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—MAPK3—atherosclerosis	8.48e-07	2.47e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PPARG—atherosclerosis	8.47e-07	2.47e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CXCL8—atherosclerosis	8.44e-07	2.46e-05	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—AKT1—atherosclerosis	8.44e-07	2.46e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—SERPINE1—atherosclerosis	8.42e-07	2.46e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—MTHFR—atherosclerosis	8.34e-07	2.43e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—INS—atherosclerosis	8.31e-07	2.43e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—IL6—atherosclerosis	8.3e-07	2.42e-05	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—AKT1—atherosclerosis	8.3e-07	2.42e-05	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	8.28e-07	2.42e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PIK3CG—atherosclerosis	8.27e-07	2.41e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—MAPK3—atherosclerosis	8.2e-07	2.39e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—MAPK3—atherosclerosis	8.2e-07	2.39e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—STAT3—atherosclerosis	8.19e-07	2.39e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PPARA—atherosclerosis	8.18e-07	2.39e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—IL6—atherosclerosis	8.17e-07	2.38e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—IL6—atherosclerosis	8.15e-07	2.38e-05	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—AKT1—atherosclerosis	8.15e-07	2.38e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—SERPINE1—atherosclerosis	8.15e-07	2.38e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—SERPINE1—atherosclerosis	8.15e-07	2.38e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—VEGFA—atherosclerosis	8.08e-07	2.36e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NOS3—atherosclerosis	8.04e-07	2.35e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—IL6—atherosclerosis	8.02e-07	2.34e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—STAT3—atherosclerosis	8e-07	2.33e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PPARG—atherosclerosis	7.98e-07	2.33e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—AGT—atherosclerosis	7.93e-07	2.31e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—STAT3—atherosclerosis	7.92e-07	2.31e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—STAT3—atherosclerosis	7.92e-07	2.31e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MMP9—atherosclerosis	7.9e-07	2.3e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—INS—atherosclerosis	7.83e-07	2.29e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—MAPK3—atherosclerosis	7.83e-07	2.28e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—HMOX1—atherosclerosis	7.82e-07	2.28e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—NFKB1—atherosclerosis	7.81e-07	2.28e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—ALB—atherosclerosis	7.81e-07	2.28e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NOS3—atherosclerosis	7.78e-07	2.27e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NOS3—atherosclerosis	7.78e-07	2.27e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MMP9—atherosclerosis	7.77e-07	2.27e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—APOE—atherosclerosis	7.77e-07	2.27e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MMP9—atherosclerosis	7.75e-07	2.26e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CAV1—atherosclerosis	7.69e-07	2.25e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—NFKB1—atherosclerosis	7.69e-07	2.24e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MAPK8—atherosclerosis	7.68e-07	2.24e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—APOA1—atherosclerosis	7.68e-07	2.24e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—NFKB1—atherosclerosis	7.67e-07	2.24e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—AKT1—atherosclerosis	7.66e-07	2.24e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IL6—atherosclerosis	7.66e-07	2.23e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—MAPK3—atherosclerosis	7.64e-07	2.23e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MMP9—atherosclerosis	7.63e-07	2.23e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—ALB—atherosclerosis	7.62e-07	2.22e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—TGFB1—atherosclerosis	7.59e-07	2.22e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—MAPK3—atherosclerosis	7.57e-07	2.21e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—MAPK3—atherosclerosis	7.57e-07	2.21e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MAPK8—atherosclerosis	7.56e-07	2.21e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—NFKB1—atherosclerosis	7.55e-07	2.2e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IL6—atherosclerosis	7.55e-07	2.2e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MAPK8—atherosclerosis	7.54e-07	2.2e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—AKT1—atherosclerosis	7.54e-07	2.2e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—AKT1—atherosclerosis	7.52e-07	2.19e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—APOB—atherosclerosis	7.49e-07	2.19e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—NOS3—atherosclerosis	7.47e-07	2.18e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MAPK8—atherosclerosis	7.42e-07	2.17e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TGFB1—atherosclerosis	7.41e-07	2.16e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—AKT1—atherosclerosis	7.4e-07	2.16e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—TGFB1—atherosclerosis	7.34e-07	2.14e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—TGFB1—atherosclerosis	7.34e-07	2.14e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—NOS3—atherosclerosis	7.29e-07	2.13e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GSTM1—atherosclerosis	7.28e-07	2.13e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ALB—atherosclerosis	7.18e-07	2.1e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—LPL—atherosclerosis	7.15e-07	2.09e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CXCL8—atherosclerosis	7.13e-07	2.08e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—VEGFA—atherosclerosis	7.09e-07	2.07e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—AKT1—atherosclerosis	7.07e-07	2.06e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—STAT3—atherosclerosis	7.02e-07	2.05e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PIK3CG—atherosclerosis	7.01e-07	2.05e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—VEGFA—atherosclerosis	6.98e-07	2.04e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GPX1—atherosclerosis	6.98e-07	2.04e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—VEGFA—atherosclerosis	6.96e-07	2.03e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—AKT1—atherosclerosis	6.96e-07	2.03e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—STAT3—atherosclerosis	6.91e-07	2.02e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CXCL8—atherosclerosis	6.9e-07	2.01e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CXCL8—atherosclerosis	6.9e-07	2.01e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—STAT3—atherosclerosis	6.9e-07	2.01e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—NOS3—atherosclerosis	6.87e-07	2e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—VEGFA—atherosclerosis	6.85e-07	2e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—PTGS2—atherosclerosis	6.83e-07	1.99e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CD36—atherosclerosis	6.79e-07	1.98e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—STAT3—atherosclerosis	6.78e-07	1.98e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL6—atherosclerosis	6.78e-07	1.98e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PPARG—atherosclerosis	6.76e-07	1.97e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—MAPK3—atherosclerosis	6.71e-07	1.96e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—PTGS2—atherosclerosis	6.67e-07	1.95e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—INS—atherosclerosis	6.63e-07	1.94e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—MAPK3—atherosclerosis	6.6e-07	1.93e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—MAPK3—atherosclerosis	6.59e-07	1.92e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL6—atherosclerosis	6.56e-07	1.91e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL6—atherosclerosis	6.56e-07	1.91e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TGFB1—atherosclerosis	6.51e-07	1.9e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—MAPK3—atherosclerosis	6.48e-07	1.89e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL6—atherosclerosis	6.47e-07	1.89e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MMP9—atherosclerosis	6.45e-07	1.88e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—MTHFR—atherosclerosis	6.44e-07	1.88e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL6—atherosclerosis	6.41e-07	1.87e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TGFB1—atherosclerosis	6.41e-07	1.87e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TGFB1—atherosclerosis	6.39e-07	1.87e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—NFKB1—atherosclerosis	6.38e-07	1.86e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PPARA—atherosclerosis	6.32e-07	1.84e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TGFB1—atherosclerosis	6.29e-07	1.84e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—PTGS2—atherosclerosis	6.28e-07	1.83e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MAPK8—atherosclerosis	6.27e-07	1.83e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—AKT1—atherosclerosis	6.26e-07	1.83e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MMP9—atherosclerosis	6.24e-07	1.82e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MMP9—atherosclerosis	6.24e-07	1.82e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL6—atherosclerosis	6.2e-07	1.81e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—NFKB1—atherosclerosis	6.17e-07	1.8e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—NFKB1—atherosclerosis	6.17e-07	1.8e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—AKT1—atherosclerosis	6.14e-07	1.79e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—AGT—atherosclerosis	6.12e-07	1.79e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ALB—atherosclerosis	6.08e-07	1.77e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MAPK8—atherosclerosis	6.07e-07	1.77e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MAPK8—atherosclerosis	6.07e-07	1.77e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—AKT1—atherosclerosis	6.05e-07	1.77e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—AKT1—atherosclerosis	6.05e-07	1.77e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL6—atherosclerosis	5.99e-07	1.75e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL6—atherosclerosis	5.99e-07	1.75e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—APOE—atherosclerosis	5.99e-07	1.75e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—AKT1—atherosclerosis	5.97e-07	1.74e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CAV1—atherosclerosis	5.94e-07	1.73e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—APOA1—atherosclerosis	5.92e-07	1.73e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—AKT1—atherosclerosis	5.91e-07	1.73e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—NOS3—atherosclerosis	5.82e-07	1.7e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—VEGFA—atherosclerosis	5.79e-07	1.69e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—STAT3—atherosclerosis	5.74e-07	1.67e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—IL6—atherosclerosis	5.72e-07	1.67e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—AKT1—atherosclerosis	5.72e-07	1.67e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—VEGFA—atherosclerosis	5.6e-07	1.64e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—VEGFA—atherosclerosis	5.6e-07	1.64e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL6—atherosclerosis	5.59e-07	1.63e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—STAT3—atherosclerosis	5.55e-07	1.62e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—STAT3—atherosclerosis	5.55e-07	1.62e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—IL6—atherosclerosis	5.53e-07	1.62e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—IL6—atherosclerosis	5.53e-07	1.62e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—AKT1—atherosclerosis	5.53e-07	1.61e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—AKT1—atherosclerosis	5.53e-07	1.61e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—MAPK3—atherosclerosis	5.48e-07	1.6e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	5.41e-07	1.58e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—PTGS2—atherosclerosis	5.32e-07	1.55e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TGFB1—atherosclerosis	5.32e-07	1.55e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—MAPK3—atherosclerosis	5.3e-07	1.55e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—MAPK3—atherosclerosis	5.3e-07	1.55e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—AKT1—atherosclerosis	5.28e-07	1.54e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PPARG—atherosclerosis	5.22e-07	1.52e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—AKT1—atherosclerosis	5.15e-07	1.5e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TGFB1—atherosclerosis	5.14e-07	1.5e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TGFB1—atherosclerosis	5.14e-07	1.5e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—INS—atherosclerosis	5.12e-07	1.49e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—AKT1—atherosclerosis	5.11e-07	1.49e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—AKT1—atherosclerosis	5.11e-07	1.49e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—IL6—atherosclerosis	4.91e-07	1.43e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL6—atherosclerosis	4.83e-07	1.41e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL6—atherosclerosis	4.82e-07	1.41e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL6—atherosclerosis	4.74e-07	1.38e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ALB—atherosclerosis	4.69e-07	1.37e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—AKT1—atherosclerosis	4.53e-07	1.32e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—NOS3—atherosclerosis	4.49e-07	1.31e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—AKT1—atherosclerosis	4.45e-07	1.3e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—AKT1—atherosclerosis	4.45e-07	1.3e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—AKT1—atherosclerosis	4.44e-07	1.3e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—AKT1—atherosclerosis	4.44e-07	1.3e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—AKT1—atherosclerosis	4.42e-07	1.29e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—AKT1—atherosclerosis	4.37e-07	1.28e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—AKT1—atherosclerosis	4.28e-07	1.25e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—AKT1—atherosclerosis	4.28e-07	1.25e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.11e-07	1.2e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL6—atherosclerosis	4.01e-07	1.17e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL6—atherosclerosis	3.88e-07	1.13e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—IL6—atherosclerosis	3.88e-07	1.13e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—AKT1—atherosclerosis	3.7e-07	1.08e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—AKT1—atherosclerosis	3.58e-07	1.04e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—AKT1—atherosclerosis	3.58e-07	1.04e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—AKT1—atherosclerosis	3.43e-07	1e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—AKT1—atherosclerosis	3.35e-07	9.78e-06	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—AKT1—atherosclerosis	3.16e-07	9.21e-06	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—AKT1—atherosclerosis	2.67e-07	7.8e-06	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—AKT1—atherosclerosis	2.06e-07	6.02e-06	CbGpPWpGaD
